Dysautonomia in Guillain–Barré Syndrome: Prevalence, Clinical Spectrum, and Outcomes
Guillain–Barré syndrome (GBS), when severe, involves the autonomic nervous system; our objective was to assess the spectrum and predictors of dysautonomia, and how it may impact functional outcomes.
A retrospective review of patients admitted to the Mayo Clinic in Rochester, MN between January 1, 2000, and December 31, 2017, with GBS and dysautonomia was performed. Demographics, comorbidities, parameters of dysautonomia, clinical course, GBS disability score, and Erasmus GBS Outcome Score (EGOS) at discharge were recorded.
One hundred eighty seven patients were included with 71 (38%) noted to have at least one manifestation of dysautonomia. There are 72% of patients with a demyelinating form of GBS and 36% of patients with demyelination had dysautonomia. Ileus (42%), hypertension (39%), hypotension (37%), fever (29%), tachycardia or bradycardia (27%), and urinary retention (24%) were the most common features. Quadriparesis, bulbar and neck flexor weakness, and mechanical ventilation were associated with autonomic dysfunction. Patients with dysautonomia more commonly had cardiogenic complications, syndrome of inappropriate antidiuretic hormone, posterior reversible encephalopathy syndrome, and higher GBS disability score and EGOS. Mortality was 6% in patients with dysautonomia versus 2% in the entire cohort (P = 0.02).
Dysautonomia in GBS is a manifestation of more severe involvement of the peripheral nervous system. Accordingly, mortality and functional outcomes are worse. There is a need to investigate if more aggressive treatment is warranted in this category of GBS.
KeywordsDysautonomia Guillain–Barré syndrome Acute inflammatory demyelinating polyradiculoneuropathy Autonomic dysfunction
Acute demyelinating polyradiculoneuropathy
Intensive care unit
Posterior reversible encephalopathy syndrome
Syndrome of inappropriate antidiuretic hormone
Erasmus GBS Outcome Score
Chronic inflammatory polyradiculoneuropathy
Compound muscle action potential
Deep vein thrombus
No other acknowledgements.
This study required no sponsorship or funding. Tia Chakraborty MD authored, conceptualized, acquired data, performed all statistical analyses, drafted, and revised the manuscript. She had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Christopher Kramer MD analyzed and acquired data, conceptualized, drafted, and revised the manuscript. Eelco Wijdicks MD PhD authored, conceptualized, drafted, and revised the manuscript. Alejandro A. Rabinstein MD authored, conceptualized, drafted, and revised the manuscript.
Source of Support
Conflict of interest
All authors declare that they have no conflict of interest.
Ethical Approval/Informed Consent
The Mayo Clinic Institutional Review Board approved this study.
- 1.Wijdicks EF, Klein CJ. Guillain–Barre syndrome. Mayo Clin Proc. 2017;92(3):467–79.Google Scholar
- 2.Flachenecker P, Hartung HP, Reiners K. Power spectrum analysis of heart rate variability in Guillain–Barré syndrome. A longitudinal study. Brain. 1997;120(10):1885–94.Google Scholar
- 3.Tuck RR, McLeod JG. Autonomic dysfunction in Guillain–Barre syndrome. J Neurol Neurosurg Psychiatry. 1981;44(11):983–90.Google Scholar
- 4.Guz A, et al. The role of vagal and glossopharyngeal afferent nerves in respiratory sensation, control of breathing and arterial pressure regulation in conscious man. Clin Sci. 1966;30(1):161–70.Google Scholar
- 5.Pfeiffer G. Dysautonomia in Guillain–Barre syndrome. Nervenarzt. 1999;70(2):136–48.Google Scholar
- 7.Banakar BF, et al. Guillain–Barre syndrome with posterior reversible encephalopathy syndrome. J Neurosci Rural Pract. 2014;5(1):63–5.Google Scholar
- 8.Ropper AH, Wijdicks EFM, Truax BT. Guillain–Barré syndrome. Contemporary neurology series. F.A. Davis: Philadelphia; 1991.Google Scholar
- 9.Singh NK, et al. Assessment of autonomic dysfunction in Guillain–Barre syndrome and its prognostic implications. Acta Neurol Scand. 1987;75(2):101–5.Google Scholar
- 10.Pfeiffer G, et al. Indicators of dysautonomia in severe Guillain–Barre syndrome. J Neurol. 1999;246(11):1015–22.Google Scholar
- 11.van Koningsveld R, et al. A clinical prognostic scoring system for Guillain–Barre syndrome. Lancet Neurol. 2007;6(7):589–94.Google Scholar
- 12.Hocker SE, et al. Indicators of central fever in the neurologic intensive care unit. JAMA Neurol. 2013;70(12):1499–504.Google Scholar
- 13.Fugate JE, Rabinstein AA. The diagnosis of posterior reversible encephalopathy syndrome—authors’ reply. Lancet Neurol. 2015;14(11):1075.Google Scholar
- 14.Hughes RA, et al. Controlled trial prednisolone in acute polyneuropathy. Lancet. 1978;2(8093):750–3.Google Scholar
- 15.Yuki N, Hartung HP. Guillain–Barre syndrome. N Engl J Med. 2012;366(24):2294–304.Google Scholar
- 16.Guillain–Barre Syndrome Study Group. Guillain–Barre syndrome: an Italian multicentre case-control study. Neurol Sci. 2000;21(4):229–34.Google Scholar
- 17.Zochodne DW. Autonomic involvement in Guillain–Barre syndrome: a review. Muscle Nerve. 1994;17(10):1145–55.Google Scholar
- 18.Winer JB, Hughes RA, Osmond C. A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry. 1988;51(5):605–12.Google Scholar
- 19.Haymaker WE, Kernohan JW. The Landry–Guillain–Barre syndrome; a clinicopathologic report of 50 fatal cases and a critique of the literature. Medicine (Baltimore). 1949;28(1):59–141.Google Scholar
- 20.Lichtenfeld P. Autonomic dysfunction in the Guillain–Barre syndrome. Am J Med. 1971;50(6):772–80.Google Scholar
- 21.Bredin CP. Guillain–Barre syndrome: the unsolved cardiovascular problems. Ir J Med Sci. 1977;146(9):273–9.Google Scholar
- 22.Soffer D, Feldman S, Alter M. Clinical features of the Guillain–Barre syndrome. J Neurol Sci. 1978;37(1–2):135–43.Google Scholar
- 23.Greenland P, Griggs RC. Arrhythmic complications in the Guillain–Barre syndrome. Arch Intern Med. 1980;140(8):1053–5.Google Scholar
- 24.Burns TM, et al. Adynamic ileus in severe Guillain–Barre syndrome. Muscle Nerve. 2001;24(7):963–5.Google Scholar
- 25.Zaeem Z, Siddiqi ZA, Zochodne DW. Autonomic involvement in Guillain–Barre syndrome: an update. Clin Auton Res. 2019;29(3):289–99.Google Scholar
- 26.Anandan C, Khuder SA, Koffman BM. Prevalence of autonomic dysfunction in hospitalized patients with Guillain–Barre syndrome. Muscle Nerve. 2017;56(2):331–3.Google Scholar
- 27.Elahi A, Kelkar P, St Louis EK. Posterior reversible encephalopathy syndrome as the initial manifestation of Guillain–Barre Syndrome. Neurocrit Care. 2004;1(4):465–8.Google Scholar
- 28.Van Diest D, et al. Posterior reversible encephalopathy and Guillain–Barre syndrome in a single patient: coincidence or causative relation? Clin Neurol Neurosurg. 2007;109(1):58–62.Google Scholar
- 29.McLeod JG. Invited review: autonomic dysfunction in peripheral nerve disease. Muscle Nerve. 1992;15(1):3–13.Google Scholar
- 30.Asahina M, et al. Autonomic function in demyelinating and axonal subtypes of Guillain–Barre syndrome. Acta Neurol Scand. 2002;105(1):44–50.Google Scholar